Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Machine learning can help find new ways to treat alopecia areata.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Six months after COVID-19, most patients still had autoantibodies.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

CS12192 effectively treats alopecia areata with better safety than current options.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

IL-17-producing γδ T cells help improve bone healing.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Red tattoo ink may cause skin growths, needing careful monitoring.

Human thymus has stem cells that can self-renew and maintain their identity.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.